A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions
NCT05665283
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Bioequivalency
Interventions
DRUG:
Ensartinib Hydrochloride
Sponsor
Xcovery Holdings, Inc.